Literature DB >> 11903934

Scaling for size: some implications for paediatric anaesthesia dosing.

Brian J Anderson1, George H Meakin.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 11903934     DOI: 10.1046/j.1460-9592.2002.00616.x

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


× No keyword cloud information.
  32 in total

Review 1.  Dose estimation for children.

Authors:  Nigel Baber; Deborah Pritchard
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

2.  What is the right dose for children?

Authors:  Massimo Cella; Catherijne Knibbe; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2010-10       Impact factor: 4.335

3.  Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Michael P Eaton; George M Alfieris; Dawn M Sweeney; Ronald E Angona; Jill M Cholette; Charles Venuto; Brian Anderson
Journal:  Anesthesiology       Date:  2015-05       Impact factor: 7.892

Review 4.  Population clinical pharmacology of children: modelling covariate effects.

Authors:  Brian J Anderson; Karel Allegaert; Nicholas H G Holford
Journal:  Eur J Pediatr       Date:  2006-06-29       Impact factor: 3.183

5.  Limited predictability of amikacin clearance in extreme premature neonates at birth.

Authors:  Karel Allegaert; Brian J Anderson; Veerle Cossey; Nicholas H G Holford
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

Review 6.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

7.  Model Informed Dose Optimization of Dichloroacetate for the Treatment of Congenital Lactic Acidosis in Children.

Authors:  Naveen Mangal; Margaret O James; Peter W Stacpoole; Stephan Schmidt
Journal:  J Clin Pharmacol       Date:  2017-09-15       Impact factor: 3.126

8.  Intravenous indometacin in preterm infants with symptomatic patent ductus arteriosus. A population pharmacokinetic study.

Authors:  J M Smyth; P S Collier; M Darwish; J S Millership; H L Halliday; S Petersen; J C McElnay
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

9.  Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates.

Authors:  Karel Allegaert; Brian J Anderson; Gunnar Naulaers; Jan de Hoon; Rene Verbesselt; Anne Debeer; Hugo Devlieger; Dick Tibboel
Journal:  Eur J Clin Pharmacol       Date:  2004-04-08       Impact factor: 2.953

10.  Population pharmacokinetics of remifentanil in infants and children undergoing cardiac surgery.

Authors:  Wai Johnn Sam; Gregory B Hammer; David R Drover
Journal:  BMC Anesthesiol       Date:  2009-07-27       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.